JPWO2023090411A5 - - Google Patents
Info
- Publication number
- JPWO2023090411A5 JPWO2023090411A5 JP2023562411A JP2023562411A JPWO2023090411A5 JP WO2023090411 A5 JPWO2023090411 A5 JP WO2023090411A5 JP 2023562411 A JP2023562411 A JP 2023562411A JP 2023562411 A JP2023562411 A JP 2023562411A JP WO2023090411 A5 JPWO2023090411 A5 JP WO2023090411A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- skeletal muscle
- pharmaceutical composition
- condition
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021188247 | 2021-11-19 | ||
| PCT/JP2022/042796 WO2023090411A1 (ja) | 2021-11-19 | 2022-11-18 | 心疾患または骨格筋の疾患の治療用医薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023090411A1 JPWO2023090411A1 (https=) | 2023-05-25 |
| JPWO2023090411A5 true JPWO2023090411A5 (https=) | 2025-11-26 |
Family
ID=86397177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023562411A Pending JPWO2023090411A1 (https=) | 2021-11-19 | 2022-11-18 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250041279A1 (https=) |
| EP (1) | EP4434520A4 (https=) |
| JP (1) | JPWO2023090411A1 (https=) |
| WO (1) | WO2023090411A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3796975T (lt) | 2018-05-22 | 2023-12-11 | Orsobio, Inc. | Sulfonilaminobenzamido dariniai |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060178400A1 (en) | 2004-11-05 | 2006-08-10 | Beutel Bruce A | Novel acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| EP1996567B1 (en) | 2006-02-15 | 2013-09-18 | AbbVie Inc. | Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| CA2648748A1 (en) | 2006-04-14 | 2007-10-25 | Takeda Pharmaceutical Company Limited | Nitrogen-containing heterocyclic compound |
| WO2008079610A2 (en) | 2006-12-21 | 2008-07-03 | Abbott Laboratories | Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| US20100093777A1 (en) | 2007-01-25 | 2010-04-15 | Takeda Pharmaceutical Company Limited | Spiro-ring compound |
| JPWO2008102749A1 (ja) | 2007-02-20 | 2010-05-27 | 武田薬品工業株式会社 | 複素環化合物 |
| JP2009196966A (ja) | 2008-02-25 | 2009-09-03 | Takeda Chem Ind Ltd | ピラゾリジンジオン誘導体 |
| UY31968A (es) | 2008-07-09 | 2010-01-29 | Sanofi Aventis | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos |
| WO2010050445A1 (ja) | 2008-10-27 | 2010-05-06 | 武田薬品工業株式会社 | 二環性化合物 |
| EP2947082A1 (en) | 2009-11-10 | 2015-11-25 | Pfizer Inc | N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS |
| WO2011136385A1 (en) * | 2010-04-27 | 2011-11-03 | Takeda Pharmaceutical Company Limited | Bicyclic compound derivatives and their use as acc inhibitors. |
| ES2536319T3 (es) | 2010-11-30 | 2015-05-22 | Takeda Pharmaceutical Company Limited | Compuestos bicíclicos como inhibidores de acetil-CoA carboxilasa (ACC) |
| CN103945840A (zh) | 2011-08-26 | 2014-07-23 | 国立大学法人大阪大学 | 糖尿病性心血管并发症的预防/治疗剂 |
| WO2013035827A1 (ja) | 2011-09-09 | 2013-03-14 | 塩野義製薬株式会社 | 新規オレフィン誘導体 |
| RS57157B1 (sr) | 2011-11-11 | 2018-07-31 | Gilead Apollo Llc | Acc inhibitori i njihove primene |
| US8530460B2 (en) | 2011-12-19 | 2013-09-10 | Boehringer Ingelheim International Gmbh | Azetidine derivatives |
| US9169205B2 (en) | 2012-10-08 | 2015-10-27 | Boehringer Ingelheim International Gmbh | Pyrrolidine derivatives, pharmaceutical compositions and uses thereof |
| WO2014061693A1 (ja) | 2012-10-17 | 2014-04-24 | 塩野義製薬株式会社 | 新規非芳香族炭素環又は非芳香族複素環誘導体 |
| US20160220557A1 (en) | 2013-09-12 | 2016-08-04 | Pfizer Inc. | Use of acetyl-coa carboxylase inhibitors for treating acne vulgaris |
| EP3670496A3 (en) | 2013-10-17 | 2020-09-30 | Shionogi&Co., Ltd. | Acc2 inhibitors |
| JP6559228B2 (ja) | 2014-09-17 | 2019-08-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 肥満症及び糖尿病の治療に有用なテトラヒドロイソキノリン誘導体及び医薬組成物 |
| JP2016079168A (ja) | 2014-10-17 | 2016-05-16 | 塩野義製薬株式会社 | ９員縮合環誘導体 |
| EA201791258A1 (ru) | 2015-01-09 | 2017-12-29 | Джилид Аполло, Ллс | Комбинированная терапия с применением ингибитора ацетил-коа-карбоксилазы (acc) для лечения неалкогольной жировой болезни печени |
| EP3266454A1 (en) | 2016-07-07 | 2018-01-10 | Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften | Acc inhibitors for use in treating mycobacterial diseases |
| EP4154880A4 (en) | 2020-05-21 | 2024-06-05 | Shionogi & Co., Ltd | Pharmaceutical for treating fatty liver diseases |
-
2022
- 2022-11-18 JP JP2023562411A patent/JPWO2023090411A1/ja active Pending
- 2022-11-18 EP EP22895692.6A patent/EP4434520A4/en active Pending
- 2022-11-18 WO PCT/JP2022/042796 patent/WO2023090411A1/ja not_active Ceased
- 2022-11-18 US US18/710,725 patent/US20250041279A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019531320A5 (https=) | ||
| JP5014120B2 (ja) | 酸化窒素生物活性を有する活性酸素生成酵素阻害剤およびそれらの使用 | |
| JPWO2023090411A5 (https=) | ||
| JP5470046B2 (ja) | Ｐａｉ−１産生抑制剤 | |
| CA2962922C (en) | Sphingosine-1-phosphate receptor modulators for treatment of cardiopulmonary disorders | |
| JP2018501285A5 (https=) | ||
| NO20045557L (no) | Kombinasjon av en DPP IV inhibitor og en kardiovaskulaer forbindelse | |
| JP2007517833A5 (https=) | ||
| JP2021519764A5 (https=) | ||
| FI3562487T3 (fi) | Metalloentsyymi-inhibiittoriyhdisteitä | |
| JP2022514254A5 (https=) | ||
| JPWO2023195529A5 (https=) | ||
| JP2022527270A5 (https=) | ||
| JP2016522196A5 (https=) | ||
| JP2009543844A5 (https=) | ||
| RU2009135821A (ru) | Применение четвертичных соединений пиридиния для вазопротекции и/или гепатопротекции | |
| DAVID | Combined cardiac and abdominal aortic surgery | |
| JP2021520394A5 (https=) | ||
| JP2022502467A5 (https=) | ||
| EP2113502B1 (fr) | Composés de type hydrazide et leur utilisation dans des compositions pharmaceutiques pour le traitement des maladies cardiovasculaires | |
| JP2010534670A5 (https=) | ||
| JP2005515994A5 (https=) | ||
| JP2015519334A (ja) | 抗血小板薬のプロドラッグ | |
| JP2022544803A5 (https=) | ||
| JP2021527071A5 (https=) |